This page is specifically intended to support patients who have been prescribed Xolair by their UK healthcare provider. If you have any questions about your medication, ask your doctor, nurse or pharmacist and read the patient information leaflet provided with your medicine.

 

__________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________

Below you will find a range of resources developed to help you manage your chronic spontaneous urticaria (CSU) and use Xolair. These resources provide information on injecting Xolair at home, as well as guidance on how to track changes in your symptoms. If you require any further information or are concerned about any aspect of the injection, talk to your healthcare professional.

Preview image of Xolair patient self-administration online starter kit.

Xolair patient self-administration online starter kit

Digital copies of the Xolair starter kit booklets. These PDF documents give you more information about your condition and treatment, and important allergy information.

It also includes a step-by-step guide for using Xolair at home, and tools to help you keep track of your symptoms, treatment and important contacts.

View

 

Preview imaghe of Instruction video for Xolair self-injection for patients.

For patients: Instruction video for Xolair self-injection

A short video to support you to inject your Xolair at home, once you’ve been trained by your healthcare provider.

You can read more about Xolair and how to use it in the patient information leaflet (PIL)

This link will take you to the electronic medicines compendium (emc) website, which is a non-Novartis website.*

View

 

Preview image of Instruction video for Xailr injection for carers.

For carers: Instruction video for Xolair injection

A short video to support carers who have been trained to inject Xolair at home.

You can read more about Xolair and how to use it in the patient information leaflet (PIL)

This link will take you to the electronic medicines compendium (emc) website, which is a non-Novartis website.*

View

 

Preview image of MyTherapy App.

MyTherapy App

Novartis have partnered with MyTherapy to grant you free access to the Xolair content on the MyTherapy app.

Access your unique link here to download the Xolair MyTherapy app content and help you transition to using Xolair at home with dosing reminders, symptom tracking, and more.

Find out more

 

Preview image of Patient personal tracker questionnaires.

Patient personal tracker questionnaires

Daily, weekly and monthly personal tracker questionnaires to allow you to track your symptoms and monitor your disease yourself.

View

 

*The PIL is the leaflet included in the pack with a medicine. It is written for patients and gives information about taking or using a medicine. It is possible that the leaflet in your medicine pack may differ from this version because it may have been updated since your medicine was packaged.

Rate this content: 
No votes yet
UK | March 2022 | 164029
×

Ask Speakers

×

Medical Information Request

Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You should also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk.
By reporting side effects you can help provide more information on the safety of this medicine.